Peptide NGR Modified TiO2 Nanofiber Substrate for Circulating Tumor Cells Capture

Changchong Chen,Zeen Wu,Pi Ding,Na Sun,Hui Liu,Yong Chen,Zhili Wang,Renjun Pei
DOI: https://doi.org/10.1007/s42765-020-00040-0
IF: 12.958
2020-05-14
Advanced Fiber Materials
Abstract:The analysis of circulating tumor cells (CTCs) allows a noninvasive method of “real-time liquid biopsy” from the blood samples of cancer patients for the diagnosis of early-stage cancer, prognosis, and monitoring therapeutic response. In this study, we develop a simple, inexpensive, and reliable method that utilizes a small molecule peptide, the asparagine-glycine-arginine (NGR), as a capture probe for the selective enrichment and isolation of circulating tumor cells (CTCs). The multiscale TiO2 nanofibers are obtained by electrospinning and calcination. Bovine serum albumin (BSA) is decorated onto TiO2 nanofiber surfaces to inhibit non-target cell adhesion, while NGR peptides are conjugated onto the TiO2-BSA surface through the glutaraldehyde (GA) to specifically capture the target cells. The TiO2-BSA-NGR substrate exhibits a high capture sensitivity and efficiency from the mimical blood samples with PC-3 cancer cells as low as 10 cells/mL. The TiO2 nanofiber substrate can be a promising strategy for the capture and enumeration of CTCs in cancer progression monitoring.Graphic Abstract
materials science, multidisciplinary, textiles
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is to develop a simple, cost - effective and reliable method for efficiently capturing circulating tumor cells (CTCs) from blood samples of cancer patients. Specifically, the authors use a small - molecule peptide - asparagine - glycine - arginine (NGR) as a probe, combined with a titanium dioxide (TiO₂) nanofiber substrate, to achieve the selective enrichment and separation of CTCs. This method aims to improve the capture sensitivity and efficiency of CTCs, thereby providing a non - invasive "real - time liquid biopsy" means for early cancer diagnosis, treatment response monitoring and prognosis evaluation. It is mentioned in the article that the number of CTCs in peripheral blood is extremely scarce, which poses a great challenge to detection. Therefore, the development of an efficient CTCs capture strategy is crucial for clinical applications. The TiO₂ nanofiber substrate modification method proposed in this paper can not only effectively reduce the adhesion of non - target cells, but also specifically capture target cells through NGR peptides, showing high capture sensitivity and efficiency. Experimental results show that this substrate can exhibit good capture performance even when the CTCs concentration in simulated blood samples is as low as 10 cells/mL, and has potential clinical application value.